Officer received an award of 19K MRNA derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jul 5, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 7, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001682852-26-000131
- Filed / recorded
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly Reporting personSoria Ester Banque Officer titleChief Commercial Officer SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateJul 5, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- 25% of this option will vest and become exercisable on July 5, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Around the same time
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.